Li et al. discovered that elevated ApoA-I inhibits the movement and invasion of neutrophils at tumor sites rich in chronic inflammatory factors, thereby reducing the number of neutrophils infiltrating tumor tissue and ultimately increasing the survival rate [12]. This evidence concerns the gene APOA1 and neoplasm.